ANDREA HARVEY: Open Payments
NPI 1629722475 · GRETNA, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,081 in 53 payments from 10 companies in 2025. Trend: 2023 $420 · 2024 $893 · 2025 $1,081
Food & beverage: $1,081
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $506 |
| ABBVIE INC. | 20 | $200 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $103 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $63 |
| Lilly USA, LLC | 3 | $60 |
| Exact Sciences Corporation | 3 | $53 |
| PFIZER INC. | 2 | $50 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $21 |
| Biogen, Inc. | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $5 |
Products named: AIRSUPRA, FARXIGA, Kerendia, QULIPTA, UBRELVY, CAPLYTA, The Cologuard Plus Collection Kit, NURTEC ODT.
Industry payments across VA — which companies pay providers there.
